Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?

References

1. Bland J. M., Altman D. G. 1998; Survival probabilities (the Kaplan-Meier method). BMJ 317:1572 [CrossRef]
   [Google Scholar]
2. Bland J. M., Altman D. G. 2004; The logrank test. BMJ 328:1073 [CrossRef]
   [Google Scholar]
3. Freedman D. O., Weld L. H., Kozarsky P. E., Fisk T., Robins R., von Sonnenberg F., Keystone J. S., Pandey P., Cetron M. S. other authors 2006; Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354:119–130 [CrossRef]
   [Google Scholar]
4. Hakanen A., Kotilainen P., Jalava J., Siitonen A., Huovinen P. 1999; Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37:3572–3577
   [Google Scholar]
5. Kadhiravan T., Wig N., Kapil A., Kabra S. K., Renuka K., Misra A. 2005; Cinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi . BMC Infect Dis 5:37 [CrossRef]
   [Google Scholar]
6. Nkemngu N. J., Asonganyi E. D., Njunda A. L. 2005; Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. BMC Infect Dis 5:49 [CrossRef]
   [Google Scholar]
7. Parry C. M. 2004; The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 98:413–422 [CrossRef]
   [Google Scholar]
8. Parry C. M., Hien T. T., Dougan G., White N. J., Farrar J. J. 2002; Typhoid fever. N Engl J Med 347:1770–1782 [CrossRef]
   [Google Scholar]
9. Rahman M., Siddique A. K., Shoma S., Rashid H., Salam M. A., Ahmed Q. S., Nair G. B., Breiman R. F. 2006; Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 134:433–438
   [Google Scholar]
10. Renuka K., Sood S., Das B. K., Kapil A. 2005; High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 54:999–1000 [CrossRef]
    [Google Scholar]
11. Slinger R., Desjardins M., McCarthy A. E., Ramotar K., Jessamine P., Guibord C., Toye B. 2004; Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility. BMC Infect Dis 4:36 [CrossRef]
    [Google Scholar]
12. Wain J., Diep T. S., Ho V. A., Walsh A. M., Nguyen T. T., Parry C. M., White N. J. 1998; Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 36:1683–1687
    [Google Scholar]